These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 34067881)

  • 1. Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man.
    Fabiani M; Margiotti K; Viola A; Mesoraca A; Giorlandino C
    Pathogens; 2021 May; 10(5):. PubMed ID: 34067881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity.
    Fakhroo A; AlKhatib HA; Al Thani AA; Yassine HM
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.
    Wilton T; Bujaki E; Klapsa D; Majumdar M; Zambon M; Fritzsche M; Mate R; Martin J
    mSystems; 2021 Jun; 6(3):e0035321. PubMed ID: 34128696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.
    Sallam M; Mahafzah A
    Pathogens; 2021 Mar; 10(3):. PubMed ID: 33807556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant.
    Edara VV; Floyd K; Lai L; Gardner M; Hudson W; Piantadosi A; Waggoner JJ; Babiker A; Ahmed R; Xie X; Lokugamage K; Menachery V; Shi PY; Suthar MS
    medRxiv; 2021 Feb; ():. PubMed ID: 33564782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19.
    Gómez CE; Perdiguero B; Esteban M
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33799505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA-Based Vaccine BNT162b2 Might Reduce Severe Acute Respiratory Syndrome Coronavirus 2 B.1.1.7 Variant Transmission in Japanese Population.
    Matsunaga T; Higashidate Y; Inazawa N; Ando S; Takahashi M
    Cureus; 2021 Oct; 13(10):e19140. PubMed ID: 34737915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development.
    Akkiz H
    Front Med (Lausanne); 2021; 8():636532. PubMed ID: 34026780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants.
    Anichini G; Terrosi C; Gori Savellini G; Gandolfo C; Franchi F; Cusi MG
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34069852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.
    Hui DS; Zumla A; Tang JW
    Curr Opin Pulm Med; 2021 May; 27(3):146-154. PubMed ID: 33660619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).
    Cavalcanti E; Isgrò MA; Rea D; Di Capua L; Trillò G; Russo L; Botti G; Miscio L; Buonaguro FM; Bianchi AAM
    Infect Agent Cancer; 2021 May; 16(1):32. PubMed ID: 33980271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients.
    Walker SN; Chokkalingam N; Reuschel EL; Purwar M; Xu Z; Gary EN; Kim KY; Helble M; Schultheis K; Walters J; Ramos S; Muthumani K; Smith TRF; Broderick KE; Tebas P; Patel A; Weiner DB; Kulp DW
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32855181
    [No Abstract]   [Full Text] [Related]  

  • 15. Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants.
    Zimerman RA; Cadegiani FA; Pereira E Costa RA; Goren A; Campello de Souza B
    Cureus; 2021 Mar; 13(3):e13819. PubMed ID: 33728228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
    Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
    Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual.
    Kernéis S; Planas D; Imbeaud S; Staropoli I; Puech J; Robillard N; Rodary J; Bruel T; Vieillard T; Schwartz O; Belec L; Péré H; Veyer D
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab369. PubMed ID: 34377731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.
    Khoury R; Bernstein PS; Debolt C; Stone J; Sutton DM; Simpson LL; Limaye MA; Roman AS; Fazzari M; Penfield CA; Ferrara L; Lambert C; Nathan L; Wright R; Bianco A; Wagner B; Goffman D; Gyamfi-Bannerman C; Schweizer WE; Avila K; Khaksari B; Proehl M; Heitor F; Monro J; Keefe DL; D'Alton ME; Brodman M; Makhija SK; Dolan SM
    Obstet Gynecol; 2020 Aug; 136(2):273-282. PubMed ID: 32555034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.